Delivery Order SPE2DB20D1109-SPE2DB25FP65S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $11,498.68. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for completion by August 21, 2025. The award supports pharmaceutical procurement for federal medical needs, with performance occurring at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $6,612.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger federal contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $4,628.35. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $16,311.04. This competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $36,207.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.12 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $50,589.89 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.31 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP65SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count packages) with a contract ceiling value of $4,407.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's larger federal contracting relationship with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen holds a critical role in supplying medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/27/25 |